Treatment after chemo - PARP inhibito... - Advanced Prostate...

Advanced Prostate Cancer

22,372 members28,135 posts

Treatment after chemo - PARP inhibitor or immunotherapy trial?

WhiteStrat profile image
5 Replies

After completing 7 rounds of docetaxel, my PSA went from 32 to 8. Bone scan and CT show no disease progression but no significant decrease either. The majority of my mets are in bone with several suspicious lymph nodes.

Without going into great detail about my history, I was initially diagnosed in Jan., 2011 with a PSA of 18 and the cancer out of the prostate. RP, radiation; I have been on ADT since 2011. I've taken Xtandi and Abiraterone. I had Provenge in 2016.

I have discussed the next step with my MO at MD Anderson. One option is a PARP inhibitor. Caris genomic testing of my original tumor shows, in what I think is relevant, the following: 1)mutations in BRCA1, PTEN, EP300, and NTRK3; 2) Mismatch repair status = proficient; and 3) PD-L1 = negative.

Trying a PARP inhibitor seems like the next choice to me. But, there is an immunotherapy trial, nivolumab and ipilimumab, at MD Anderson that my MO suggests I try. She also indicated we might try the PARP inhibitor with the immunotherapy.

At some point, I assume I will try Lu-177 and Ac-225. I applied for this to Heidelberg last Fall and was told my PSMA expression was not high enough for them at that time.

Any advice would be, as usual, greatly appreciated.

Written by
WhiteStrat profile image
WhiteStrat
To view profiles and participate in discussions please or .
Read more about...
5 Replies
Tall_Allen profile image
Tall_Allen

I vote for the PARP inhibitor with the immunotherapy. Your BRCA1 qualifies you for the PARP inhibitor, and I expect it will last longer with the immunotherapy. If it works, maybe follow with Jevtana+Carboplatin. I know MDAnderson has a big trial of the reverse sequence, but I don't know of any reason that PARP first may be equally beneficial.

WhiteStrat profile image
WhiteStrat in reply toTall_Allen

Thank you for your prompt reply. I try to be realistic about this disease (and its progression) but I am cautiously optimistic I can knock it back a little bit with these treatments.

scarlino profile image
scarlino

I will be entering the trial at MD Anderson using Keytruda and the PARP inhibitor Oliparib. I will post when it starts for me, probably end of August.

j-o-h-n profile image
j-o-h-n in reply toscarlino

Knock em dead............

Good Luck, Good Health and Good Humor.

j-o-h-n Thursday 07/23/2020 5:37 PM DST

scarlino profile image
scarlino in reply toj-o-h-n

Thanks! I hope it does something.

Not what you're looking for?

You may also like...

azd5305 PARP inhibitor

I had the chance to ask a doctor about this, the doctor is the chief of this trial in one center of...
Maxone73 profile image

Chemo/Pluvicto or Clinical Trial?

I have stage 4, mcrpc with mets to pelvic lymph nodes and prostate. ADT (Firmagon and Zytiga) kept...
carguy profile image

Started PARP inhibitor Olaparib and Provenge treatment

I am BRCA2+. Was on Zytiga for just six months after it initially lowered my PSA from 20 to 0.12,...

Proton Therapy Had PT Therapy 15 years (2009) ago 5 year follow Up No Cancer Just Diagnosed with Mets in Bone/Pelvic Lymph Nodes in 2024

Had PT Therapy at MD Anderson 15 years ago with Pencil beam radiation. Gleason at the time 2009...
Rcole727 profile image

Abiraterone plus PARP inhibitors after Taxotere- has anyone received health insurance approval?

I've just finished 6 rounds of chemotherapy (Taxotere). Next step per my MO and urologist is to...
tallguy2 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.